Literature DB >> 28807867

Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.

Maria Francesca Bedeschi1, Giuseppe Marangi2, Maria Rosaria Calvello1, Stefania Ricciardi2, Francesca Pia Chiara Leone2, Marco Baccarin3, Silvana Guerneri3, Daniela Orteschi2, Marina Murdolo2, Serena Lattante2, Silvia Frangella2, Beth Keena4, Margaret H Harr4, Elaine Zackai4, Marcella Zollino5.   

Abstract

Pitt-Hopkins syndrome is a neurodevelopmental disorder characterized by severe intellectual disability and a distinctive facial gestalt. It is caused by haploinsufficiency of the TCF4 gene. The TCF4 protein has different functional domains, with the NLS (nuclear localization signal) domain coded by exons 7-8 and the bHLH (basic Helix-Loop-Helix) domain coded by exon 18. Several alternatively spliced TCF4 variants have been described, allowing for translation of variable protein isoforms. Typical PTHS patients have impairment of at least the bHLH domain. To which extent impairment of the remaining domains contributes to the final phenotype is not clear. There is recent evidence that certain loss-of-function variants disrupting TCF4 are associated with mild ID, but not with typical PTHS. We describe a frameshift-causing partial gene deletion encompassing exons 4-6 of TCF4 in an adult patient with mild ID and nonspecific facial dysmorphisms but without the typical features of PTHS, and a c.520C > T nonsense variant within exon 8 in a child presenting with a severe phenotype largely mimicking PTHS, but lacking the typical facial dysmorphism. Investigation on mRNA, along with literature review, led us to suggest a preliminary phenotypic map of loss-of-function variants affecting TCF4. An intragenic phenotypic map of loss-of-function variants in TCF4 is suggested here for the first time: variants within exons 1-4 and exons 4-6 give rise to a recurrent phenotype with mild ID not in the spectrum of Pitt-Hopkins syndrome (biallelic preservation of both the NLS and bHLH domains); variants within exons 7-8 cause a severe phenotype resembling PTHS but in absence of the typical facial dysmorphism (impairment limited to the NLS domain); variants within exons 9-19 cause typical Pitt-Hopkins syndrome (impairment of at least the bHLH domain). Understanding the TCF4 molecular syndromology can allow for proper nosology in the current era of whole genomic investigations.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  NLS domain; Pitt-Hopkins syndrome; TCF4; bHLH domain

Mesh:

Substances:

Year:  2017        PMID: 28807867     DOI: 10.1016/j.ejmg.2017.08.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  9 in total

1.  Mutations in Mediator Complex Genes CDK8, MED12, MED13, and MEDL13 Mediate Overlapping Developmental Syndromes.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2019-08-16

Review 2.  Transcription factor 4 and its association with psychiatric disorders.

Authors:  José R Teixeira; Ryan A Szeto; Vinicius M A Carvalho; Alysson R Muotri; Fabio Papes
Journal:  Transl Psychiatry       Date:  2021-01-05       Impact factor: 6.222

3.  Enriched environment ameliorates adult hippocampal neurogenesis deficits in Tcf4 haploinsufficient mice.

Authors:  Katharina Braun; Benjamin M Häberle; Marie-Theres Wittmann; D Chichung Lie
Journal:  BMC Neurosci       Date:  2020-11-23       Impact factor: 3.288

4.  Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of Tcf4 expression.

Authors:  Hyojin Kim; Eric B Gao; Adam Draper; Noah C Berens; Hanna Vihma; Xinyuan Zhang; Alexandra Higashi-Howard; Kimberly D Ritola; Jeremy M Simon; Andrew J Kennedy; Benjamin D Philpot
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

5.  Pitt-Hopkins syndrome: phenotypic and genotypic description of four unrelated patients and structural analysis of corresponding missense mutations.

Authors:  Tingting Zhao; Georgi Z Genchev; Shengnan Wu; Guangjun Yu; Hui Lu; Jincai Feng
Journal:  Neurogenetics       Date:  2021-06-14       Impact factor: 2.660

Review 6.  Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.

Authors:  Huei-Ying Chen; Joseph F Bohlen; Brady J Maher
Journal:  Dev Neurosci       Date:  2021-06-16       Impact factor: 3.421

7.  Region and Cell Type Distribution of TCF4 in the Postnatal Mouse Brain.

Authors:  Hyojin Kim; Noah C Berens; Nicole E Ochandarena; Benjamin D Philpot
Journal:  Front Neuroanat       Date:  2020-07-17       Impact factor: 3.856

8.  Pitt-Hopkins Syndrome: Clinical and Molecular Findings of a 5-Year-Old Patient.

Authors:  Florin Tripon; Alina Bogliș; Cristian Micheu; Ioana Streață; Claudia Bănescu
Journal:  Genes (Basel)       Date:  2020-05-28       Impact factor: 4.096

Review 9.  Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes.

Authors:  Iria Roca; Ana Fernández-Marmiesse; Sofía Gouveia; Marta Segovia; María L Couce
Journal:  Int J Mol Sci       Date:  2018-05-27       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.